PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Things Pharmaceutical Supply Chain and Operations Directors Should Know, But Do Not

In considering supply chain operations in pharmaceuticals businesses, the naïve amongst us might assume that the answers to the basic questions are clear. How much inventory is enough?  What does it cost to make a tablet? Which plants are the most efficient producers? How much capacity do we have? How should we plan and organise how demand hits operations? What doesit cost to serve the customer? Dr John Harhen at Orbsen Consulting discusses that there is a fundamental lack of clarity to these most basic of questions.
 

https://international-pharma.com/wp-content/uploads/2012/12/1-Things-Pharmaceutical-Supply-Chain-and-Operations-Directors-Should-Know-But-Do-Not.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026